REQUEST A DEMO
Total
USD $0.00
Search more companies

B D Pharmaceutical Works Private Limited (India)

Main Activities: Basic Chemical Manufacturing
Full name: B D Pharmaceutical Works Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

B D Pharmaceutical Works Private Limited is an enterprise in India, with the main office in Kolkata. It operates in the Basic Chemical Manufacturing sector. B D Pharmaceutical Works Private Limited was incorporated on March 19, 2009. The company’s latest financial report indicates a net sales revenue increase of 11.26% in 2024. A growth of 6.97% was recorded in its total assets. The net profit margin of B D Pharmaceutical Works Private Limited increased by 1.97% in 2024.

Legal Address
48 Ezra Street,Giria Trade Centr1St Floor, Unit No. 116
Kolkata; West Bengal; Postal Code: 700001

Contact Details: Purchase the B D Pharmaceutical Works Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the B D Pharmaceutical Works Private Limited report to view the information.
Financial Auditors:
Purchase the B D Pharmaceutical Works Private Limited report to view the information.
Incorporation Date:
March 19, 2009
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after B D Pharmaceutical Works Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
11.26%
Total Operating Revenue
11.35%
Operating Profit
48.17%
EBITDA
25.68%
Net Profit/Loss for the Period
49.06%
Total Assets
6.97%
Total Equity
9.58%
Operating Profit Margin
2.68%
Net Profit Margin
1.97%
Return on Equity (ROE)
2.33%
Quick Ratio
2.8%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?